Cosmos Health COSM
NASDAQ COSM
$0.25 0.00 (-0.71%)
At close: Sep 10, 2026 · 4:00 PM EDT

Cosmos Health (COSM) Capital Expenditures (2015 - 2026)

Cosmos Health's (COSM) quarterly Capital Expenditures came in at $63637.0 in Q2 2026, up 182.4% on a YoY basis from $22534.0 in Q2 2025, and up 458.27% quarter-over-quarter from $11399.0 in Q1 2026.

Analysis

Cosmos Health (COSM) Capital Expenditures (2015 - 2026) Analysis & Trends

Cosmos Health (COSM) has reported Capital Expenditures for 12 consecutive years, with $63637.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Capital Expenditures rose 182.4% year-over-year to $63637.0; the trailing twelve-month figure through Jun 2026 stood at $95647.0 (down 71.56% YoY), and the FY2025 full-year result was $55675.0, down 86.68% from the prior year.
  • Capital Expenditures improved to $63637.0 in Q2 2026 per COSM's latest filing, from $11399.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $1.2 million in Q2 2023 and bottomed at $4438.0 in Q1 2022.
  • Historically, Capital Expenditures has averaged $107566.0 across 5 years, with a median of $26568.0 in 2022.
  • The sharpest annual moves came in 2022 and 2023: Capital Expenditures tumbled 98.9% in 2022, then surged 4414.92% in 2023.
  • Over 5 years, Capital Expenditures stood at $37070.0 in 2022, then increased by 25.99% to $46705.0 in 2023, then jumped by 55.19% to $72482.0 in 2024, then plunged by 89.11% to $7895.0 in 2025, then surged by 706.04% to $63637.0 in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods registered $63637.0, $11399.0, and $7895.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Teva Pharmaceutical Industries 42.33 Bn 38.68 Bn 2.15 Bn 104.00 Mn
2 Viatris 19.05 Bn 18.16 Bn 1.46 Bn 52.80 Mn
3 Dr Reddys Laboratories 9.76 Bn 9.58 Bn 396.53 Mn -36.19 Mn
4 Amneal Pharmaceuticals 5.38 Bn 5.25 Bn 334.51 Mn 30.70 Mn
5 Bausch Health Companies 2.27 Bn 436.38 Mn 2.10 Bn 77.00 Mn
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn -27.87 Mn
7 Ani Pharmaceuticals 1.51 Bn 1.15 Bn 165.89 Mn 3.05 Mn
8 Amphastar Pharmaceuticals 1.03 Bn 737.26 Mn 93.47 Mn 8.59 Mn
9 Fennec Pharmaceuticals 393.12 Mn 351.87 Mn 17.15 Mn -
10 Cosmos Health 15.08 Mn 12.63 Mn 1.51 Mn 63,637.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63,637.00
Mar 31, 2026 11,399.00
Dec 31, 2025 7,895.00
Sep 30, 2025 12,716.00
Jun 30, 2025 22,534.00
Mar 31, 2025 12,530.00
Dec 31, 2024 72,482.00
Sep 30, 2024 228,767.00
Jun 30, 2024 34,164.00
Mar 31, 2024 82,662.00
Dec 31, 2023 46,705.00
Sep 30, 2023 16,557.00
Jun 30, 2023 1.22 Mn
Mar 31, 2023 26,028.00
Dec 31, 2022 37,070.00
Sep 30, 2022 5,591.00
Jun 30, 2022 27,108.00
Mar 31, 2022 4,438.00
Dec 31, 2021 59,640.00
Sep 30, 2021 509,658.00